Literature DB >> 26047392

Effect of nefopam- versus fentanyl-based patient-controlled analgesia on postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery: a prospective double-blind randomized controlled trial.

Chung-Sik Oh1, Eugene Jung, Sun Joo Lee, Seong-Hyop Kim.   

Abstract

OBJECTIVE: This study comparatively evaluated the effect of patient-controlled analgesia (PCA) regimens using equipotent doses of nefopam or fentanyl during laparoscopic gynecological surgery on postoperative nausea and vomiting (PONV). RESEARCH DESIGN AND METHODS: Patients undergoing gynecological laparoscopic surgery were randomly allocated to receive either nefopam- (non-opioid; N group) or fentanyl-based (F group) PCA. PONV and postoperative pain were assessed during the 72 hours following discharge from the post-anesthetic care unit (PACU). The adverse effects of nefopam were also evaluated. CLINICAL TRIAL REGISTRATION: Cris.nih.go.kr ID KCT0000783.
RESULTS: In total, 94 patients were included in the final analysis. The PONV incidence and scale and the Rhodes index scores were significantly lower in the N group than the F group at all measured times. The N group exhibited a significantly lower incidence of PONV (15/47 [31.9%] vs. 27/47 [57.4%], respectively; P = 0.022) and severity of PONV (0 [1] vs. 1 [2], respectively; P = 0.005) 24 hours after PACU discharge and a significantly lower Rhodes index score (0 [3] vs. 5 [9], respectively; P = 0.002) from 30 minutes after PACU arrival to 24 hours after PACU discharge than did the F group. There was no significant difference in postoperative pain at any time between the two groups. Dry mouth on PACU arrival was significantly more frequent in the N group. However, the frequency of dry mouth decreased after PACU arrival in the N group, resulting in a significantly lower incidence 24 hours after PACU discharge.
CONCLUSIONS: Use of a PCA regimen with nefopam for analgesia was associated with a similar degree of pain control and superior PONV outcomes 24 hours after PACU discharge and no adverse events compared with a PCA regimen using an equipotent dose of fentanyl.

Entities:  

Keywords:  Fentanyl; Nefopam; Patient-controlled analgesia; Postoperative nausea and vomiting

Mesh:

Substances:

Year:  2015        PMID: 26047392     DOI: 10.1185/03007995.2015.1058251

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  12 in total

Review 1.  Postoperative Nausea and Vomiting in Female Patients Undergoing Breast and Gynecological Surgery: A Narrative Review of Risk Factors and Prophylaxis.

Authors:  Marco Echeverria-Villalobos; Juan Fiorda-Diaz; Alberto Uribe; Sergio D Bergese
Journal:  Front Med (Lausanne)       Date:  2022-07-01

2.  Physicochemical stability of nefopam and nefopam/droperidol solutions in polypropylene syringes for intensive care units.

Authors:  Elise D'Huart; Jean Vigneron; Igor Clarot; Béatrice Demoré
Journal:  Eur J Hosp Pharm       Date:  2019-06-11

Review 3.  Postoperative pain management in the postanesthesia care unit: an update.

Authors:  Jie Luo; Su Min
Journal:  J Pain Res       Date:  2017-11-16       Impact factor: 3.133

4.  Opioid sparing effect and safety of nefopam in patient controlled analgesia after laparotomy: A randomized, double blind study.

Authors:  Hyun Seung Jin; Yong Chul Kim; Yongjae Yoo; Changsoon Lee; Chan Woo Cho; Won-Joong Kim
Journal:  J Int Med Res       Date:  2016-06-29       Impact factor: 1.671

5.  Association of nefopam use with postoperative nausea and vomiting in gynecological patients receiving prophylactic ramosetron: A retrospective study.

Authors:  Sun-Kyung Park; Seokha Yoo; Won Ho Kim; Young-Jin Lim; Jae-Hyon Bahk; Jin-Tae Kim
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

6.  Median effective dose of nefopam to treat postoperative pain in patients who have undergone laparoscopic cholecystectomy.

Authors:  Heezoo Kim; Dong Kyu Lee; Mi Kyoung Lee; Mido Lee
Journal:  J Int Med Res       Date:  2018-05-30       Impact factor: 1.671

7.  Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial.

Authors:  Eunhye Choi; Myong-Hwan Karm; Eunsun So; Yoon Ji Choi; Sookyung Park; Yul Oh; Hye Joo Yun; Hyun Jeong Kim; Kwang-Suk Seo
Journal:  J Dent Anesth Pain Med       Date:  2019-02-28

8.  Comparison of Sufentanil- and Fentanyl-based Intravenous Patient-controlled Analgesia on Postoperative Nausea and Vomiting after Laparoscopic Nephrectomy: A Prospective, Double-blind, Randomized-controlled Trial.

Authors:  Hye-Mi Lee; Hae Keum Kil; Bon Nyeo Koo; Min Sup Song; Jin Ha Park
Journal:  Int J Med Sci       Date:  2020-01-14       Impact factor: 3.738

9.  Predicted Versus Non-Predicted Opioid Administration Using Preoperative Pain Sensitivity in Patients Undergoing Gynecological Surgery: A Randomized-Controlled Trial.

Authors:  Sun-Kyung Park; Hansol Kim; Seokha Yoo; Won Ho Kim; Young-Jin Lim; Jin-Tae Kim
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

Review 10.  Perioperative Intravenous Patient-Controlled Analgesic Efficacy of Morphine with Combined Nefopam and Parecoxib versus Parecoxib in Gynecologic Surgery: A Randomized, Double-Blind Study.

Authors:  Varinee Lekprasert; Lapuskorn Yapanan; Wichai Ittichaikulthol; Rungrawan Buachai; Phimol Soisod; Areepan Sophonsritsuk
Journal:  Anesthesiol Res Pract       Date:  2021-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.